Core Viewpoint - The stock of Kefu Medical (301087) has experienced a decline in price and significant net outflow of funds, indicating potential challenges in market sentiment and performance [1][2]. Group 1: Stock Performance - As of August 22, 2025, Kefu Medical's stock closed at 40.71 yuan, down 1.19% with a turnover rate of 2.05% and a trading volume of 39,900 hands, resulting in a transaction amount of 162 million yuan [1]. - Over the past five days, the stock has shown a consistent downward trend, with a total net outflow of main funds amounting to 4,563.78 million yuan and a net inflow from retail investors of 4,375.03 million yuan [2]. Group 2: Financial Metrics - Kefu Medical's total market capitalization is 8.512 billion yuan, with a net asset value of 4.909 billion yuan and a net profit of 914.251 million yuan [3]. - The company's price-to-earnings ratio (P/E) stands at 23.28, significantly lower than the industry average of 77.99, indicating a potentially undervalued stock [3]. - The gross margin is reported at 52.17%, slightly above the industry average of 51.31%, while the net profit margin is 12.41%, higher than the industry average of 10.85% [3]. Group 3: Recent Ratings and Target Price - In the last 90 days, one institution has given a rating of "buy" for Kefu Medical, with an average target price set at 45.0 yuan [4].
股票行情快报：可孚医疗（301087）8月22日主力资金净卖出2148.19万元